Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

FO-2546F: ACAT inhibitor from Albophoma yamanashiensis

May 17, 1996

Creative Biomolecules, Stryker extend OP-1 agreement

May 17, 1996

Estraderm MX launched in U.K.

May 10, 1996

Estring approved for marketing in U.S.

May 10, 1996

Muse safety and efficacy reported at urology meeting

May 10, 1996

Sildenafil demonstrates efficacy in erectile dysfunction Rx

May 10, 1996

AI-401 progresses to phase II

May 10, 1996

EU approval granted for Humalog

May 10, 1996

Sandoz synthesizes new antidiabetic agents

May 10, 1996

Yakult claims ACAT inhibitor from natural source

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...